Stay updated on Ublituximab in RMS: Clinical Trial

Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ublituximab in RMS: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the study details related to the efficacy and safety of Ublituximab in participants with Relapsing Forms of Multiple Sclerosis (RMS) in the ULTIMATE II study.
    Difference
    0.2%
    Check dated 2024-06-06T14:35:14.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying the diagnosis, disease activity, and disability status required for inclusion in the study. Previously, no information was provided under Participation Criteria.
    Difference
    16%
    Check dated 2024-05-22T21:28:55.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:06.000Z thumbnail image

Stay in the know with updates to Ublituximab in RMS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.